Clinical Trial Update: Efficacy and Safety of Adding Azarga to Prostaglandin Monotherapy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating adding Azarga (brimonidine tartrate/timolol) to prostaglandin monotherapy for glaucoma, focusing on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Azarga (brinzolamide; timolol maleate)

Snippet

Sponsor: Alcon Research | Conditions: Glaucoma | Phase 4 | Status: COMPLETED